Boys with Duchenne muscular dystrophy (DMD) experience poor muscle regeneration, but the precise reasons for this remain under investigation. An
Continue reading »
Home »
Non-vitamin K oral anticoagulants may be best for early-stage CKD
(HealthDay)—Non-vitamin K oral anticoagulants (NOACs) have a superior benefit-risk profile to that of vitamin K antagonists (VKAs) for patients with
Continue reading »
NIH begins testing Ebola treatment in early-stage trial
A first-in-human trial evaluating an experimental treatment for Ebola virus disease has begun at the National Institutes of Health (NIH)
Continue reading »